About galsulfase
Enzyme replacement therapy
Used for
- Treats mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome).
Usual adult dose
1 mg/kg by intravenous infusion once weekly.
Usual dose in children
1 mg/kg by intravenous infusion once weekly; used in children.
Common side effects
- Infusion reactions, including fever, chills, rash, or breathing problems
- Headache
- Nausea or vomiting
- Joint or muscle pain
Important warnings
- Infusion reactions can be severe, including anaphylaxis.
- Breathing complications may occur, especially with sleep apnea or respiratory illness.
- Antibodies to galsulfase may develop and affect treatment.
- Treatment should be given where severe allergic reactions can be managed.
Pregnancy
Use during pregnancy only when clearly needed; human pregnancy data are limited.
Breastfeeding
It is unknown whether galsulfase passes into breast milk; discuss benefits and risks.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.